The information you will find here is for healthcare professionals only.
Swedish Orphan Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. The company head office is located in Sweden.
Using its expertise and experience, Swedish Orphan Biovitrum takes scientific innovation in the rare disease area to patients with significant medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within our prioritized areas of hemophilia, inflammation/ autoimmune diseases and malabsorption.
Swedish Orphan Biovitrum offers more than 50 different medicines in a wide range of therapy areas.Through our marketing and sales force, we currently promote and sell prescription drugs in therapeutic areas such as rheumatology, hematology/ hemophilia, oncology, metabolic disease, cardiology, gastroenterology, infectious disease, nephrology and emergency medicine. The products that we market are both proprietary and promoted under licensing or distribution ageements with other leading pharmaceutical companies.
Swedish Orphan Biovitrum is present through its own local affiliates throughout Europe and in the USA and our products have an even wider reach through distributors in Africa, Asia, Australia and South America.
We constantly strive to improve the medicines and services we provide to patients worldwide and we can be successful in this mission only through dialogue with you as health care professionals. Our representatives, locally or at headquarters in Stockholm, will always appreciate your feedback and will do their utmost to provide the service and support that you can expect from a company focusing on patients with significant medical needs.